Your browser doesn't support javascript.
loading
Montrer: 20 | 50 | 100
Résultats 1 - 1 de 1
Filtrer
Plus de filtres











Base de données
Gamme d'année
1.
Zhongguo Shi Yan Xue Ye Xue Za Zhi ; 31(3): 902-906, 2023 Jun.
Article de Chinois | MEDLINE | ID: mdl-37356958

RÉSUMÉ

Obesity-associated protein (FTO) is an important m6A demethylase that regulates RNA methylation modification and can promote the proliferation of acute myeloid leukemia(AML) cells. FTO regulates the methylation level of AML through multiple cellular signaling pathways such as FTO/RARA/ASB2, FTO/m6A/CEBPA, and PDGFRB/ERK, and participates in the occurrence, development, treatment and prognosis of AML. At present, studies have found that a variety of inhibitors targeting FTO have shown good anti-leukemia effects, and the study of FTO will provide new ideas for the treatment of AML. This review focus on the mechanism of action of FTO in AML and the research progress of FTO inhibitors in AML.


Sujet(s)
Leucémie aigüe myéloïde , Humains , Méthylation , Leucémie aigüe myéloïde/génétique , Pronostic , Alpha-ketoglutarate-dependent dioxygenase FTO/génétique , Alpha-ketoglutarate-dependent dioxygenase FTO/métabolisme
SÉLECTION CITATIONS
DÉTAIL DE RECHERCHE